Evergreen Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-835
| Closed | -$470K | – | 575 |
|
|
2022
Q1 | $470K | Buy |
835
+2
| +0.2% | +$1.13K | 0.02% | 389 |
|
|
2021
Q4 | $629K | Sell |
833
-5
| -0.6% | -$3.78K | 0.03% | 341 |
|
|
2021
Q3 | $625K | Buy |
838
+6
| +0.7% | +$4.48K | 0.03% | 330 |
|
|
2021
Q2 | $536K | Buy |
832
+3
| +0.4% | +$1.93K | 0.03% | 329 |
|
|
2021
Q1 | $473K | Sell |
829
-6
| -0.7% | -$3.42K | 0.02% | 326 |
|
|
2020
Q4 | $487K | Buy |
835
+53
| +7% | +$30.9K | 0.03% | 293 |
|
|
2020
Q3 | $403K | Buy |
782
+9
| +1% | +$4.64K | 0.03% | 285 |
|
|
2020
Q2 | $349K | Buy |
+773
| New | +$349K | 0.03% | 285 |
|